Table 3.
Factors related to ECG abnormalities in patients with cirrhosis at pre-transplant evaluation in multivariate logistic regression analysis (n = 186)
| ECG abnormality | Factor | Odds ratio (95% confidence interval) |
|---|---|---|
|
Prolonged QTc time |
Possible QT prolonging drug1 |
5.84 (1.87-18.22) |
| Alcoholic cirrhosis |
2.99 (1.25-7.18) |
|
| Age (years) |
1.06 (1.01-1.10) |
|
| Mean arterial pressure |
0.94 (0.90-.0.97) |
|
| Propranolol |
0.25 (0.1-0.65) |
|
|
Q wave |
MELD score (per 1 unit) |
1.08 (1.02–1.16) |
| Age (per year) |
1.12 (1.04-1.20) |
|
|
QRS axis deviation |
History of arterial hypertension (if yes) |
3.14 (1.16-8.47) |
| Male sex (if yes) |
4.40 (1.25-15.43) |
|
|
ST-segment depression |
History of arterial hypertension (if yes) |
7.00 (1.30-37.84) |
| Cholestatic liver disease (if yes) |
6.10 (1.24-30.15) |
|
| Any feature of CAD 2 | MELD score (per 1 unit) |
1.08 (1.02-1.14) |
| Age (per year) |
1.05 (1.01-1.09) |
|
| Viral liver disease (if yes) | 0.26 (0.08-0.84) |
GFR, Glomerular filtration rate; MELD, Model of end stage liver disease; CAD, Coronary artery disease.
1Flouroquinolones - 19, Selective serotonin re-uptake inhibitors - 10, Quinine - 6, Prepulside - 1.
2Q wave, T wave inversion and/or ST-depression (17, 18).